138 related articles for article (PubMed ID: 19854250)
1. Investigation of the role of the thiazolidinedione ring of troglitazone in inducing hepatotoxicity.
Saha S; New LS; Ho HK; Chui WK; Chan EC
Toxicol Lett; 2010 Feb; 192(2):141-9. PubMed ID: 19854250
[TBL] [Abstract][Full Text] [Related]
2. Direct toxicity effects of sulfo-conjugated troglitazone on human hepatocytes.
Saha S; New LS; Ho HK; Chui WK; Chan EC
Toxicol Lett; 2010 Jun; 195(2-3):135-41. PubMed ID: 20307632
[TBL] [Abstract][Full Text] [Related]
3. Identification of glutathione conjugates of troglitazone in human hepatocytes.
Prabhu S; Fackett A; Lloyd S; McClellan HA; Terrell CM; Silber PM; Li AP
Chem Biol Interact; 2002 Nov; 142(1-2):83-97. PubMed ID: 12399157
[TBL] [Abstract][Full Text] [Related]
4. Thiazolidinedione bioactivation: a comparison of the bioactivation potentials of troglitazone, rosiglitazone, and pioglitazone using stable isotope-labeled analogues and liquid chromatography tandem mass spectrometry.
Alvarez-Sanchez R; Montavon F; Hartung T; Pähler A
Chem Res Toxicol; 2006 Aug; 19(8):1106-16. PubMed ID: 16918252
[TBL] [Abstract][Full Text] [Related]
5. Pyrrolidinediones reduce the toxicity of thiazolidinediones and modify their anti-diabetic and anti-cancer properties.
Saha S; Chan DS; Lee CY; Wong W; New LS; Chui WK; Yap CW; Chan EC; Ho HK
Eur J Pharmacol; 2012 Dec; 697(1-3):13-23. PubMed ID: 23041271
[TBL] [Abstract][Full Text] [Related]
6. Metabolic activation of troglitazone: identification of a reactive metabolite and mechanisms involved.
He K; Talaat RE; Pool WF; Reily MD; Reed JE; Bridges AJ; Woolf TF
Drug Metab Dispos; 2004 Jun; 32(6):639-46. PubMed ID: 15155556
[TBL] [Abstract][Full Text] [Related]
7. Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission.
Kassahun K; Pearson PG; Tang W; McIntosh I; Leung K; Elmore C; Dean D; Wang R; Doss G; Baillie TA
Chem Res Toxicol; 2001 Jan; 14(1):62-70. PubMed ID: 11170509
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-induction dependent bioactivation of troglitazone and troglitazone quinone in vivo.
Tettey JN; Maggs JL; Rapeport WG; Pirmohamed M; Park BK
Chem Res Toxicol; 2001 Aug; 14(8):965-74. PubMed ID: 11511170
[TBL] [Abstract][Full Text] [Related]
9. Electrochemical oxidation of troglitazone: identification and characterization of the major reactive metabolite in liver microsomes.
Madsen KG; Grönberg G; Skonberg C; Jurva U; Hansen SH; Olsen J
Chem Res Toxicol; 2008 Oct; 21(10):2035-41. PubMed ID: 18788755
[TBL] [Abstract][Full Text] [Related]
10. Metabolic and non-metabolic factors determining troglitazone hepatotoxicity: a review.
Masubuchi Y
Drug Metab Pharmacokinet; 2006 Oct; 21(5):347-56. PubMed ID: 17072088
[TBL] [Abstract][Full Text] [Related]
11. Cytoprotective effect of tauroursodeoxycholate on hepatocyte apoptosis induced by peroxisome proliferator-activated receptor gamma ligand.
Nonaka M; Tazuma S; Hyogo H; Kanno K; Chayama K
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e198-206. PubMed ID: 17868335
[TBL] [Abstract][Full Text] [Related]
12. In vitro metabolism of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl)-phenyl] methyl]benzamide], a peroxisome proliferator-activated receptor alpha/gamma agonist. II. Identification of metabolites by liquid chromatography-tandem mass spectrometry.
Liu DQ; Karanam BV; Doss GA; Sidler RR; Vincent SH; Hop CE
Drug Metab Dispos; 2004 Sep; 32(9):1023-31. PubMed ID: 15319345
[TBL] [Abstract][Full Text] [Related]
13. Hepatobiliary disposition of troglitazone and metabolites in rat and human sandwich-cultured hepatocytes: use of Monte Carlo simulations to assess the impact of changes in biliary excretion on troglitazone sulfate accumulation.
Lee JK; Marion TL; Abe K; Lim C; Pollock GM; Brouwer KL
J Pharmacol Exp Ther; 2010 Jan; 332(1):26-34. PubMed ID: 19801447
[TBL] [Abstract][Full Text] [Related]
14. Differences in hepatotoxicity and gene expression profiles by anti-diabetic PPAR gamma agonists on rat primary hepatocytes and human HepG2 cells.
Guo L; Zhang L; Sun Y; Muskhelishvili L; Blann E; Dial S; Shi L; Schroth G; Dragan YP
Mol Divers; 2006 Aug; 10(3):349-60. PubMed ID: 17031537
[TBL] [Abstract][Full Text] [Related]
15. Metabolic flux profiling of reaction modules in liver drug transformation.
Yoon J; Lee K
Pac Symp Biocomput; 2007; ():193-204. PubMed ID: 17990492
[TBL] [Abstract][Full Text] [Related]
16. New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines.
Colin C; Salamone S; Grillier-Vuissoz I; Boisbrun M; Kuntz S; Lecomte J; Chapleur Y; Flament S
Breast Cancer Res Treat; 2010 Nov; 124(1):101-10. PubMed ID: 20054646
[TBL] [Abstract][Full Text] [Related]
17. Gene expression analysis of troglitazone reveals its impact on multiple pathways in cell culture: a case for in vitro platforms combined with gene expression analysis for early (idiosyncratic) toxicity screening.
Vansant G; Pezzoli P; Saiz R; Birch A; Duffy C; Ferre F; Monforte J
Int J Toxicol; 2006; 25(2):85-94. PubMed ID: 16597547
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities.
Ong MM; Latchoumycandane C; Boelsterli UA
Toxicol Sci; 2007 May; 97(1):205-13. PubMed ID: 17150972
[TBL] [Abstract][Full Text] [Related]
19. In vitro metabolism of rivoglitazone, a novel peroxisome proliferator-activated receptor γ agonist, in rat, monkey, and human liver microsomes and freshly isolated hepatocytes.
Uchiyama M; Koda H; Fischer T; Mueller J; Yamamura N; Oguchi M; Iwabuchi H; Okazaki O; Izumi T
Drug Metab Dispos; 2011 Jul; 39(7):1311-9. PubMed ID: 21511943
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of troglitazone in hepatocytes isolated from experimentally induced diabetic rats.
Meechan AJ; Henderson C; Bates CD; Grant MH; Tettey JN
J Pharm Pharmacol; 2006 Oct; 58(10):1359-65. PubMed ID: 17034659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
